On behalf of Dr. Natalie Coburn, the Department of Continuing Professional Development and Surgery at the University of Toronto, we invite you to participate in a digital seminar series. This event was filled with national and international keynote speakers, clinical case presentations and panel discussions on multidisciplinary considerations for the treatment of cholangiocarcinoma, hepatocellular carcinoma, and various advanced cancers using the hyperthermic intraperitoneal chemotherapy (HIPEC) method.
We are very pleased to host internationally renowned physicians at the forefront of improving cancer treatment and outcomes.
Each evening of the 3-part program will consist of lectures by the guest speakers, clinical case presentations and a panel discussion. The panel discussions will involve medical, surgical and radiation oncologists moderated by Ontario faculty members.
We hope that you will be able to join us for these educational seminars!
Target Audience
- Medical Oncologists
- Surgical Oncologists
- Radiation Oncologists
- Pathologists
Note: This is an unaccredited webinar series.
Multimodal management of intrahepatic cholangiocarcinoma (Past Webinar)
A two-evening series about Multimodal management of intrahepatic cholangiocarcinoma. We will review the current and evolving treatment and testing options for bile duct cancer. We will also discuss clinical decision-making with a multi-disciplinary team to optimize therapies and improve patient outcomes.
Objectives for Multimodal management of intrahepatic cholangiocarcinoma: A two-evening series about Multimodal management of intrahepatic cholangiocarcinoma. We will review the current and evolving treatment and testing options for bile duct cancer. We will also discuss clinical decision-making with a multi-disciplinary team to optimize therapies and improve patient outcomes.
Evening #1:
Wednesday, November 10, 2021
5:00 PM – 6:45 PM EST
|
5:00 |
Introductions and Land Acknowledgement |
|
5:05 |
Guest Speaker: When to resect? |
|
5:25 |
Guest Speaker: Advances in Systemic Chemotherapy |
|
5:45 |
Q&A Period |
| 6:10 | Case Presentation for next week & Closing Remarks Dr. Julie Hallet |
Evening #2:
Wednesday, November 17, 2021
5:00 PM – 6:45 PM EST
|
5:00 |
Introductions and Land Acknowledgement |
|
5:05 |
Guest Speaker: Surgical options beyond resection |
|
5:25 |
Guest Speaker: Interventional options |
|
5:45 |
Case Presentation |
|
5:50 |
Break-out room and case discussions |
|
6:15 |
Panel case discussions |
| 6:45 | Summary of seminar and closing remarks Dr. Natalie Coburn |
Faculty Biographies
Advancements in Treating Hepatocellular carcinoma (Past Program)
A two-evening series about Multimodal management of intrahepatic cholangiocarcinoma. We will review the current and evolving treatment and testing options for liver cancer. We will also discuss clinical decision-making with a multi-disciplinary team to optimize therapies and improve patient outcomes.
Evening #1:
Wednesday, February 16, 2022
5:00 PM – 6:45 PM EST
| 1700 | Welcome & land acknowledgment Dr. Natalie Coburn |
| 1705 | Medical oncologist perspective on HCC Dr. Mark Yarchoan, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center |
| 1735 | Radiation oncologist perspective on HCC Dr. Dawn Owen, Mayo Clinic |
| 1755 | Q&A Period with Canadian& International Panel |
| 1820 | Clinical Case Presentation #1 & Panel Discussion |
| 1840 | Closing Remarks Drs. Anthony Lott & Grainne O'Kane |
Evening #2:
Wednesday, February 23rd 2022
5:00 PM – 6:45 PM EST
| 1700 | Welcome & land acknowledgment Dr. Natalie Coburn |
| 1705 | Interventional radiologist perspective on HCC Sarah White, Medical College of Wisconsin |
| 1725 | Hepatologist perspective on HCC Dr. Anjana Pillai, University of Chicago Medicine Comprehensive Cancer Centre |
| 1750 | Q&A Period with Canadian & International Panel |
| 1810 | Clinical Case Presentation #2 & Panel Discussion |
| 1840 | Summary of seminar and closing remarks Dr. Natalie Coburn |
Faculty Biographies
Management of Resectable Liver Metastases in Colorectal Cancer (Past Webinar)
Friday, May 13, 2022
4:00 PM – 5:40 PM ET
| 4:00 | Welcome & land acknowledgment Dr. Natalie Coburn |
| 4:05 | Medical oncology perspective on resectable liver metastases in CRC Dr. Alan Venook, University of California, San Francisco |
| 4:35 | HPB surgery perspective on resectable liver metastases in CRC Dr. Susanne Warner, Mayo Clinic |
| 5:05 | Q&A Period with Panel Drs. Natalie Coburn, Sheron Perera, Pablo Serrano, Patricia Tang, Alan Venook and Susanne Warner |
| 5:20 | Clinical Case Presentation and Panel Discussion |
| 5:40 | Closing Remarks |
Faculty Biographies
Cancellation
Requests for cancellation must be made in writing to facmed.registration@utoronto.ca. Registrations are not transferable.
The University of Toronto reserves the right to cancel events. Registrants will be notified at the earliest possible date in the event of a cancellation. Registration fees for events cancelled by the University will be refunded; however, the University will not be liable for any loss, damages or other expenses that such cancellations may cause.
Series Sponsors
Silver
Bronze
Zoom Webinar Tips
- If you do not already have a personal zoom account, you must create your personal zoom account (to create your personal zoom account, please visit: Zoom Registration
- Use your personal zoom account to sign in for the evening’s webinar (see Zoom Registration Link as above)
- Important: This registration process will identify your attendance and allow us to track your participation – To ensure we can identify your participation, we ask that you use your full name when setting up an account so that we may track attendance.
- We recommend that you test your system in advance of the webinar
- Please mute your microphone upon entry to the webinar.
- We also ask that you not use your video to reduce lag time for everyone by saving bandwidth.
If you are new to Zoom, you may be prompted to download the app to your computer, tablet or phone before proceeding into the webinar.